Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Eif3ftm1(KOMP)Vlcg mutation
(1 available);
any
Eif3f mutation
(22 available)
|
|
|
mortality/aging
|
• no homozygous mutants are recovered at birth following heterozygous intercrosses
|
reproductive system
|
• presence of empty decidua suggests that homozygous mutants die at an early post-implantation embryonic stage
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Eif3ftm1(KOMP)Vlcg mutation
(1 available);
any
Eif3f mutation
(22 available)
|
|
|
mortality/aging
|
• less than expected heterozygotes are born from heterozygous intercrosses (39% instead of 66%) and from crosses between heterozygous and wild-type mice (37% instead of 50%)
• crosses between male or female heterozygotes and wild-type mice revealed that heterozygous lethality is not associated with the production of dysfunctional spermatozoa or oocytes
|
growth/size/body
|
• at 4-6 months of age, heterozygotes show decreased lean body mass
|
muscle
|
• at 4 months of age, skeletal muscles of heterozygous mice show a reduction of muscle fiber size (tibialis, -21%; gastrocnemius, -24%; soleus, -26%; EDL, -17%)
• however, total fiber number and fiber type remain unaffected
|
|
• adult heterozygotes show reduced skeletal muscle mass; EDL, tibialis, quadriceps, gastrocnemius and soleus muscle mass is reduced by 14-18% relative to that in wild-type controls
|
|
• during hindlimb immobilization, heterozygotes show an exacerbated immobilization-induced skeletal muscle atrophy associated with reduced protein synthesis and reduced phosphorylation of S6K1 and S6 proteins relative to wild-type controls
|
|
• skeletal muscles of heterozygous mice show a deficiency in polysome content, a reduction in protein synthesis rate and an inhibition of the mechanistic target of rapamycin (MTOR) pathway
|
homeostasis/metabolism
cellular
|
• decreased skeletal muscle mass is associated with a reduction in the protein synthesis rate and an inhibition of the MTORC1 pathway
|